Navigation Links
Can Locoregionally Recurrent Breast Cancer Be Cured?
Date:4/13/2017

Arati Chand, M.D., physician for The Oncology Institute, has made instrumental contributions to the publication of Clinical Breast Cancer's article - Can Locregionally Recurrent Breast Cancer Be Cured? This publication will help other physicians and patients with the research and understanding of how to treat patients with locoregional breast cancer recurrence.

Advances in systemic therapy have had an impact on locoregional disease, and isolated LRRs of breast cancer are dropping in incidence.The biology of the disease is the most important factor in determining the recurrence risk of the individual cancer and the outcome for the patient. Patients who have LRR without systemic recurrence may benefit from multimodal therapy with curative intent. Tumor genomic profiling and next-generation sequencing may be important in clarifying individual tumor biology and identifying patients who will benefit from curative versus palliative therapy.

Abstract:

Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer.With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.

Arati Chand, M.D., M. Firdos Ziauddin, M.D., Shou-Ching Tang, M.D., Editors. Clinical Breast Cancer. Elsevier Inc. 2017.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14205035.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Fertility Associates of Memphis Physicians Selected to Lead National Recurrent Pregnancy Loss Discussion
2. Prodigy Sports Athletes – Competitive Figure Skaters Struggle With Recurrent Injuries
3. LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
4. Medication does not reduce risk of recurrent CV events among patients with diabetes
5. Renal denervation reduces recurrent AF after ablation
6. Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
7. NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC
8. Robots from space lead to 1-stop breast cancer diagnosis treatment
9. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
10. Potential for added medical benefits uncovered for widely used breast cancer drug
11. UT Southwestern researchers discover a new driver of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... Florida Hospital ... 16, to community partners. The newly renovated ER was designed with patients in ... emergencies, eight semi-private rooms to deliver patient results, improve efficiencies and reduce length ...
(Date:8/17/2017)... ... , ... Tanya Atagi, MD, is excited to announce the addition of a ... Skin Aesthetics. , To tighten skin on the face, Exilis stimulates new collagen ... skin is revealed on all other areas of the body using radiofrequency energy. ...
(Date:8/17/2017)... ... , ... With the introduction of new devices, new features, and updates to ... smartwatch market. As of June 2017, nearly nine percent of U.S. consumers aged 18+ ... according to latest WEAR Report Industry Overview and Forecast from NPD’s Connected Intelligence, growth ...
(Date:8/17/2017)... ... August 17, 2017 , ... CareAcademy, a ... it has raised $1.675 M in seed funding to further expand its course ... Techstars Venture Capital Fund are the company’s primary investors. , Founded ...
(Date:8/17/2017)... ... ... Pot Valet is a leading provider of premium medical-grade cannabis in California. ... soon, every state in the country, the company offers patients safe, legal, and discreet ... , According to Pot Valet, all California patients have the legal right to ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
(Date:7/31/2017)... Three Tru-D SmartUVC robots have arrived at Brian ... . Tru-D, short for "Total Room Ultraviolet Disinfection," is a 5-foot-5 germ-killing ... services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs at Army ... "Although the BAACH has a very low infection ...
Breaking Medicine Technology: